Northwest Medical Specialties

Puyallup, Washington 98373-1428

3 studies enrolling now · 5 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, HER2 Mutations Breast Neoplasms, HER2 Positive Breast Neoplasms, HER2-positive Breast Cancer, Hormone Receptor Positive Breast Neoplasms, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer, Multiple Myeloma, Triple Negative Breast Neoplasms

Studies at this site

• A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer — Recruiting now
• The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study — Recruiting now
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
• A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer — Completed
• A Safety Study of SGN-LIV1A in Breast Cancer Patients — Completed